GT Medical enhances GammaTile Therapy with Cesium-131 seed business acquisition from Isoray Medical
USA —GT Medical Technologies, a US-based medical equipment manufacturer, has agreed to acquire the radioactive Cesium-131 seed business and its infrastructure from Isoray Medical, a subsidiary of Perspective Therapeutics.
This acquisition aims to fortify GT Medical’s position in the market, particularly in Surgically Targeted Radiation Therapy (STaRT) for brain tumor resection surgeries requiring adjuvant radiation therapy.
